- Total
revenue in the second quarter of fiscal year 2019 up to $648,265
- Revenue
growth is due to an increase in hemp and CBD product sales, as well as
heightened subscriptions totals
- As the
hemp and CBD markets continue to expand, ChineseInvestors.com is expecting
even stronger performance through the second half of FY2019
ChineseInvestors.com Inc. (OTCQB: CIIX), developer of a
proprietary financial news media and content platform providing information to
the global Chinese-speaking community, recently announced its financial results
for the second quarter of fiscal year 2019, pinpointing a number of important
accomplishments. A revenue increase of more than 50 percent year-over-year is
one of the key milestones presented in January 22, 2019, news release (http://ibn.fm/U36su).
One of the biggest drivers for the excellent financial
performance was the increase in hemp and CBD sales revenue. Year-over-year,
hemp and CBD sales revenues were up by eight percent.
Subscription revenues for the premier financial information
website targeting Chinese-speaking investors also increased by 40 percent
year-over-year.
These two primary factors driving the growth of
ChineseInvestors.com contributed to revenues of $648,265 for the second quarter
of fiscal year 2019. For the six months ended November 30, total revenue
reached $1,360,625, in comparison to $882,951 for the same period of 2017.
These results indicate that CIIX’s investment in existing
markets, as well as new opportunities, has paid off, as noted by
ChineseInvestors.com CEO Warren Wang. ChineseInvestors.com’s investors are
positioned to benefit from the growth drivers that have already been
implemented, including the launch of CBD Biotechnology Co. Ltd.’s Hemp Wine.
CBD Biotechnology Co Ltd. is a wholly owned
ChineseInvestors.com foreign enterprise. Hemp Wine was launched mid-January
2019. The product is a self-branded type of rice wine created to specifically
target the global Chinese wellness market. The proprietary blend includes hemp,
ginseng and other carefully chosen ingredients (http://ibn.fm/omBYw).
In 2018, CBD Biotechnology Company put many drivers in place
to fuel future growth, CFO Alex Hamilton said. The progress registered in China
is very exciting, and the company will continue to develop innovative hemp and
CBD products in the future, he concluded.
CBD Biotechnology also focuses its activities on the sales
of hemp-infused skin care products via both digital and traditional
distribution channels. The expansion of the consumer line and the prominence of
hemp/CBD products are expected to fuel further positive developments in 2019,
on top of the subscription-based services offered by ChineseInvestors.com.
According to Wang, ChineseInvestors.com is looking forward
to an even stronger performance in the upcoming months. “As we leverage the
momentum already in place, we look forward to having an even stronger second
half for FY 2019,” he noted in a news release.
The story of ChineseInvestors.com started in 1999 when the
company was set up for the purpose of providing real-time market commentary,
analysis and education-related services in Chinese via an online platform. In
addition, the company offers advertising and PR support services, direct and
online sales of hemp-based products and other related health products.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
